Kauffman Michael 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:01 pm Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Kauffman Michael | 271,888 5.200% |
-10,209 (-3.62%) |
Filing |
| 2021-02-16 4:35 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Kauffman Michael | 282,097 5.510% |
20,668 (+7.91%) |
Filing |